Zevin Asset Management LLC boosted its holdings in Danaher Co. (NYSE:DHR) by 1.2% during the 3rd quarter, Holdings Channel reports. The firm owned 67,015 shares of the conglomerate’s stock after acquiring an additional 768 shares during the period. Danaher makes up about 3.1% of Zevin Asset Management LLC’s investment portfolio, making the stock its 11th largest holding. Zevin Asset Management LLC’s holdings in Danaher were worth $9,679,000 at the end of the most recent quarter.
A number of other hedge funds have also bought and sold shares of the business. Vanguard Group Inc. boosted its position in Danaher by 1.4% in the second quarter. Vanguard Group Inc. now owns 48,262,218 shares of the conglomerate’s stock worth $6,897,635,000 after purchasing an additional 686,421 shares during the last quarter. Northern Trust Corp lifted its position in shares of Danaher by 0.5% during the 2nd quarter. Northern Trust Corp now owns 8,929,430 shares of the conglomerate’s stock valued at $1,276,194,000 after buying an additional 41,740 shares during the last quarter. Bank of New York Mellon Corp lifted its position in shares of Danaher by 3.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 5,753,246 shares of the conglomerate’s stock valued at $822,255,000 after buying an additional 188,752 shares during the last quarter. Jennison Associates LLC lifted its position in shares of Danaher by 38.4% during the 2nd quarter. Jennison Associates LLC now owns 5,135,358 shares of the conglomerate’s stock valued at $733,945,000 after buying an additional 1,424,328 shares during the last quarter. Finally, Parnassus Investments CA lifted its position in shares of Danaher by 1.2% during the 3rd quarter. Parnassus Investments CA now owns 4,772,773 shares of the conglomerate’s stock valued at $689,332,000 after buying an additional 54,323 shares during the last quarter. 78.30% of the stock is currently owned by institutional investors and hedge funds.
A number of research analysts have recently commented on DHR shares. Wolfe Research set a $154.00 price target on Danaher and gave the company a “buy” rating in a research report on Friday, October 25th. Piper Jaffray Companies upped their price target on Danaher from $148.00 to $153.00 and gave the company a “neutral” rating in a research report on Thursday, July 18th. Robert W. Baird upped their price target on Danaher from $131.00 to $148.00 and gave the company an “outperform” rating in a research report on Friday, July 19th. Needham & Company LLC dropped their price target on Danaher from $155.00 to $152.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Finally, ValuEngine cut Danaher from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Four analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Danaher presently has an average rating of “Buy” and an average target price of $145.86.
DHR traded up $0.73 during trading on Friday, reaching $135.23. 1,633,369 shares of the company were exchanged, compared to its average volume of 2,487,994. The company’s 50-day moving average is $139.07 and its two-hundred day moving average is $138.28. The company has a market cap of $95.87 billion, a price-to-earnings ratio of 29.92, a P/E/G ratio of 2.24 and a beta of 0.92. The company has a quick ratio of 3.09, a current ratio of 3.43 and a debt-to-equity ratio of 0.52. Danaher Co. has a 12-month low of $94.59 and a 12-month high of $147.33.
Danaher (NYSE:DHR) last issued its quarterly earnings data on Thursday, October 24th. The conglomerate reported $1.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.15 by $0.01. The business had revenue of $5.04 billion for the quarter, compared to analysts’ expectations of $5.02 billion. Danaher had a return on equity of 11.42% and a net margin of 12.13%. The firm’s quarterly revenue was up 3.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.10 EPS. Equities analysts forecast that Danaher Co. will post 4.76 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were issued a dividend of $0.17 per share. The ex-dividend date was Thursday, September 26th. This represents a $0.68 dividend on an annualized basis and a yield of 0.50%. Danaher’s dividend payout ratio (DPR) is 15.04%.
In related news, Chairman Mitchell P. Rales acquired 2,500 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The shares were acquired at an average price of $139.52 per share, with a total value of $348,800.00. Following the acquisition, the chairman now owns 3,030,453 shares of the company’s stock, valued at approximately $422,808,802.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 11.40% of the company’s stock.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Read More: What is the G-20?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.